POSC POSITRON CORP
Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 844985 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin-572.6%
Operating margin-2,287.6%
Net margin-2,307.6%
FCF margin—
EBITDA margin-2,278.9%
Returns
ROE-2,479.9%
ROA—
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets115.0%
Debt / equity—
Current ratio0.71x
Interest coverage-75.37x
Cash quality & payout
Operating cash flow / net income0.37x
Accruals ratio—
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2015Q32015-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $102,667 | $111,822 | $111,000 | $111,000 | $111,000 | $120,118 | $119,333 | $304,000 |
| Cost of revenue | $492,108 | $376,732 | $637,819 | $1.43M | $367,161 | $402,433 | $377,033 | $197,000 |
| Gross profit | -$389,441 | -$264,910 | -$526,819 | -$1.32M | -$256,161 | -$282,315 | -$257,700 | $107,000 |
| R&D expense | — | — | — | — | — | — | — | $2,000 |
| SG&A expense | $527,947 | $539,004 | $838,138 | $5.58M | $749,992 | $887,675 | $1.22M | $255,000 |
| Operating income | -$917,388 | -$803,914 | -$1.36M | -$6.90M | -$1.01M | -$1.17M | -$1.48M | -$170,000 |
| Interest expense | $57,069 | $21,815 | $23,349 | $30,247 | $30,247 | $29,918 | $34,926 | $141,000 |
| Pretax income | — | — | — | — | — | — | — | -$255,000 |
| Income tax | — | — | — | — | — | — | — | $0 |
| Net income | -$971,982 | -$821,400 | -$1.38M | -$6.90M | -$1.04M | -$1.19M | -$1.47M | -$255,000 |
| EBITDA | -$908,164 | -$794,313 | -$1.36M | -$6.89M | -$997,677 | -$1.17M | -$1.47M | -$138,000 |
| EPS (basic) | -0.03 | -0.03 | -0.04 | — | -0.03 | -0.04 | -0.05 | -0.02 |
| EPS (diluted) | -0.03 | -0.03 | -0.04 | — | -0.03 | -0.04 | -0.05 | -0.02 |
| Weighted avg. shares (diluted) | 32.92M | 32.85M | 32.83M | — | 31.31M | 31.31M | 29.13M | 14.28M |
| Banking | ||||||||
| Deposits | $375,000 | $375,000 | $375,000 | $375,000 | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.93M | $357,173 | $1.41M | $2.52M | — | — | — | $28,000 |
| Receivables | $20,994 | $17,561 | — | $8,333 | — | — | — | $147,000 |
| Inventory | $680,000 | $680,000 | $680,000 | $680,000 | — | — | — | $316,000 |
| Current assets | $2.88M | $1.11M | $2.15M | $3.34M | — | — | — | $514,000 |
| PP&E, net | $77,326 | $86,550 | $96,151 | $105,752 | — | — | — | $799,000 |
| Intangibles | — | — | — | — | — | — | — | $6,000 |
| Total assets | $3.66M | $1.73M | $2.79M | $4.00M | — | — | — | $1.52M |
| Current liabilities | $4.08M | $2.25M | $2.49M | $2.40M | — | — | — | $3.10M |
| Short-term debt | $210,084 | — | — | — | — | — | — | — |
| Long-term debt | $127,395 | $136,894 | $146,446 | $153,686 | — | — | — | — |
| Total debt | $337,479 | $136,894 | $146,446 | $153,686 | — | — | — | — |
| Total liabilities | $4.21M | $2.39M | $2.63M | $2.56M | — | — | — | $3.10M |
| Shareholders' equity | -$550,223 | -$660,847 | $160,553 | $1.44M | $1.36M | $2.41M | $3.42M | -$1.58M |
| Net debt | -$1.59M | -$220,279 | -$1.26M | -$2.37M | — | — | — | — |
| Shares outstanding | 33.10M | 32.85M | 32.85M | 32.80M | — | — | — | 14.28M |
| Cash flow statement | ||||||||
| Operating cash flow | -$581,520 | -$1.05M | -$788,710 | -$1.34M | -$1.04M | -$886,406 | -$1.44M | -$48,000 |
| Capital expenditure | — | — | — | — | — | — | — | $0 |
| Free cash flow | — | — | — | — | — | — | — | -$48,000 |
| Investing cash flow | — | — | — | -$22,502 | — | — | — | $0 |
| Financing cash flow | $2.15M | $0 | -$325,000 | $2.00M | $0 | $0 | $5.25M | -$13,000 |
| Depreciation & amortization | $9,224 | $9,601 | $9,601 | $9,601 | $8,476 | $4,650 | $4,650 | $32,000 |
| Stock-based compensation | $0 | $0 | $4.98M | — | — | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 29 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.